- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Almirall joins project to allow study participants to use trial data | ||
| Mo | C4XD signs NRF2 Activator deal with AstraZeneca | ||
| Fr | Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation | ||
| Fr | Depressive therapy Spravato demonstrates superior efficacy | ||
| Do | Storm doses first patient with solid tumour drug candidate | ||
| Do | Multi-drug precision medicine cancer trial begins | ||
| Mi | Study brings personalised immunotherapy prescriptions closer | ||
| Mi | Medicines for Malaria Venture and Novartis move to phase 3 trial | ||
| 22.11. | Takeda findings may minimise haemophilia treatment side effects | ||
| 22.11. | Turbine boosts AI platform to deliver cancer treatments | ||
| 21.11. | Infex begins study of pseudomonas aeruginosa candidate RESP-X | ||
| 21.11. | Iveric Bio receives new therapy designation for avacincaptad pegol | ||
| 18.11. | NICE recommends Sobi's Doptelet to treat thrombocytopenia | ||
| 18.11. | Kidney Cancer UK receives commission from NICE | ||
| 17.11. | Association of the British Pharmaceutical Industry lays down new antibiotics mission | ||
| 17.11. | NICE recommends Pfizer's Paxlovid on NHS | ||
| 16.11. | Evgen to investigate new SFX-01 tablet formulation | ||
| 16.11. | Research provides hope for patients with neurodegenerative disease | ||
| 15.11. | Sequana announces results from study of direct sodium removal | ||
| 15.11. | Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients | ||
| 14.11. | Lindis biotech presents encouraging data from bladder cancer trial | ||
| 14.11. | Priothera reveals positive mocravimod data | ||
| 11.11. | Stada and Xbrane gain EU approval for biosimilar Ximluci | ||
| 11.11. | Bristol Myers Squibb opens 125-acre biologics campus in Dublin | ||
| 10.11. | Brainomix and Visionable announce AI partnership |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
